Understanding Safety and Adverse Drug Events in Homeopathy: A Fair and Balanced Approach

Understanding Safety and Adverse Drug Events in Homeopathy: A Fair and Balanced Approach

Faculty

Jeannette Y. Wick, RPh, MBA, FASCP

Freelance Medical Writer

Arlington, Virginia

Assistant Director, Office of Pharmacy Professional Development

University of Connecticut School of Pharmacy

Storrs, Connecticut

Program Description

Homeopathic products are derived from natural sources and produced in strict adherence to the FDA-recognized Homeopathic Pharmacopoeia of the United States (HPUS). HPUS provides a set of standards for the uniform manufacturing of products, along with testing and processing the ingredients. Consumers actively seek to self-treat symptoms with homeopathic products, many of which are sold over-the-counter in pharmacies. Pharmacists are some of the most accessible health care professionals and have an opportunity to engage patients in conversation about a range of treatment options as well as appropriately answer any questions they may have regarding these products. This activity includes updates surrounding manufacturing and use of homeopathic products, reports of associated safety and adverse events, and how to best counsel patients who may be experiencing an adverse event.

Target Audience: Pharmacists

Type of Activity: Application

Release date: December 14, 2020

Expiration date: January 23, 2023

Time to complete activity: 2.0 hours

Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Examine homeopathic principles and the FDA’s risk-based regulations for homeopathic products
• Compare common homeopathic products, the symptoms for which they are used, and the likelihood of an adverse drug event based on dilutions
• Analyze Poison Control Center data to assess the safety of homeopathic products
• Identify appropriate uses and counseling points for homeopathic products

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity number 0290-0000-20-376-H01-P. The activity is available for CE credit through January 23, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, read the article in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Jeannette Wick, RPh, MBA, FASCP, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Crissy Wilson; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer

CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:

[email protected]

Privacy Policy and Terms of Use Information:

www.pharmacytimes.org/terms